Answer to Practice Problem #5 Dose- and Time-Dependent Pharmacokinetics Tutorial:

 

 

 

A drug that exhibits a high first-pass effect is one that exhibits a high intrinsic hepatic clearance. At low doses, before saturation of the enzymes occurs, as you increase the oral dose, the AUC will increase proportionally. As the oral dose is continues to be increased and the metabolizing enzymes become saturated, the fraction escaping first-pass metabolism will increase (i.e., systemic availability increases). At this point in time, the increase in AUCoral will be greater than the increase in dose (e.g., a doubling of dose will result in more than a doubling of the AUCoral). Notice for the AUCiv that for a given dose the intravenous AUC is greater than the oral AUC … because drug administered iv is not subjected to first pass metabolism. Hence, as the dose increases, the AUC will increase proportionally. To consider this mathematically, remember that

 

AUCoral = Doral/(fubCLuint)

 

As enzymes become saturated, the CLuint decreases. Hence, the AUCoral will increase disproportionately to the dose. A doubling of dose will cause more than a doubling of the AUCoral. On the other hand, for a high clearance drug

 

AUCiv = Div/CLH ~ Div/QH

 

Hence, increasing the dose will result in a proportional increase in the AUC after intravenous administration.

 

 

 

Last revised 07/14/05

 

ã 2005 -  Craig K. Svensson, Pharm.D., Ph.D.

 

Return to the Dose- and Time-Dependent Pharmacokinetics Tutorial

 

Return to the Index for Lecture Tutorials

 

Return to Pharmacokinetics and Biopharmaceutics Homepage